Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, Tahani Mazyad Almutairi, Stefan Bräse & Bahaa G. M. Youssif. (2024) Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 39:1.
Read now
Read now
Articles from other publishers (3)
Juan Zhang, Xuliang Liu, Na Sa, Jin-He Zhang, Yong-Si Cai, Kai-Ming Wang, Wei Xu, Cheng-Shi Jiang & Kong-Kai Zhu. (2024) Synthesis and biological evaluation of 1-phenyl-tetrahydro-β-carboline-based first dual PRMT5/EGFR inhibitors as potential anticancer agents. European Journal of Medicinal Chemistry 269, pages 116341.
Crossref
Crossref
Aliaa M. Mohassab, Heba A. Hassan, Hesham A. Abou-Zied, Mikako Fujita, Masami Otsuka, Hesham A. M. Gomaa, Bahaa G. M. Youssif & Mohamed Abdel-Aziz. (2024) Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases. Journal of Molecular Structure 1297, pages 136953.
Crossref
Crossref
Lamya H. Al-Wahaibi, Hesham A. Abou-Zied, Mohamed Hisham, Eman A. M. Beshr, Bahaa G. M. Youssif, Stefan Bräse, Alaa M. Hayallah & Mohamed Abdel-Aziz. (2023) Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways. Molecules 28:18, pages 6586.
Crossref
Crossref